Matter Bio
PrivateLast Round
Seed
May 29, 2024
Total Funding Raised
$7M
Company Overview
Matter Bio is a biotechnology company that develops therapeutic interventions and research services aimed at preserving genome integrity to extend human healthspan and treat age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Matter Bio Comparables
Compare Matter Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Turn Biotechnologies | 71% | |
| Editas Medicine | 70% | |
| Fauna Bio | 70% |
Matter Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 29, 2024 |
Key People
Founding team and executive leadership
Matter Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeSpan Vision Ventures | Seed |
| quadraScope Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 29, 2024
$7M round led by LifeSpan Vision Ventures
Matter Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Matter Bio's valuation, stock price, and market status.
Is Matter Bio a public or private company?
Matter Bio is a private company.
What is the current stock price of Matter Bio?
Matter Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Matter Bio worth (valuation)?
Valuation information for Matter Bio is not publicly available.
Can I buy Matter Bio stock?
Matter Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Matter Bio's last funding round?
Matter Bio's most recent funding round was Seed on May 29, 2024.
Who are the main investors in Matter Bio?
Key investors in Matter Bio include LifeSpan Vision Ventures.
Will Matter Bio IPO soon?
No public IPO plans have been announced for Matter Bio.
How can I track Matter Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Matter Bio's secondary market activity and sign up for updates.